Heart failure in congenital heart disease: management options and clinical challenges

References

• Dolk H, Loane M, Garne E, et al. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011 Mar 1;123(8):841–849. PubMed PMID: 21321151.
   PubMed Web of Science ®Google Scholar
• van der Linde D, Konings EEM, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011 Nov 15;58(21):2241–2247.
   PubMed Web of Science ®Google Scholar
• Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019 Apr 02;73(12):e81–e192.
   PubMed Web of Science ®Google Scholar
• Baumgartner H. Geriatric congenital heart disease: a new challenge in the care of adults with congenital heart disease? Eur Heart J. 2013;35(11):683–685.
   PubMed Web of Science ®Google Scholar
• van der Bom T, Bouma BJ, Meijboom FJ, et al. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am Heart J. 2012 Oct 01;164(4):568–575.
   PubMed Web of Science ®Google Scholar
• Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2013;35(11):725–732.
   PubMed Web of Science ®Google Scholar
• Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol. 2005 Jul 05;46(1):1–8.
   PubMed Web of Science ®Google Scholar
• Stout KK, Broberg CS, Book WM, et al. Chronic heart failure in congenital heart disease: a scientific statement from the American heart association. Circulation. 2016 Feb 23;133(8):770–801. PubMed PMID: 26787728.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Kalogeropoulos AP, Savvoulidis P, Saraf A, et al. Prevalence and incidence of heart failure in adolescents and adults with repaired tetralogy of Fallot. J Am Coll Cardiol. 2017;69(11 Supplement):563. DOI:10.1016/S0735-1097(17)33952-9
   Web of Science ®Google Scholar
• Norozi K, Wessel A, Alpers V, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006 Apr 15;97(8):1238–1243.
   PubMed Web of Science ®Google Scholar
• Piran S, Veldtman G, Siu S, et al. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002 Mar 12;105(10):1189–1194. PubMed PMID: 11889012.
   PubMed Web of Science ®Google Scholar
• Cuypers JAAE, Eindhoven JA, Slager MA, et al. The natural and unnatural history of the mustard procedure: long-term outcome up to 40 years. Eur Heart J. 2014;35(25):1666–1674.
   PubMed Web of Science ®Google Scholar
• Dennis M, Kotchetkova I, Cordina R, et al. Long-term follow-up of adults following the atrial switch operation for transposition of the great arteries – A contemporary cohort. Heart Lung Circ. 2018 Aug 01;27(8):1011–1017.
   PubMed Web of Science ®Google Scholar
• Graham TP, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: A multi-institutional study. J Am Coll Cardiol. 2000 Jul 01;36(1):255–261.
   PubMed Web of Science ®Google Scholar
• Rychik J, Atz AM, Celermajer DS, et al. Evaluation and management of the child and adult with fontan circulation: a scientific statement from the american heart association. Circulation. 2019;140(6):e234-e284.
   PubMed Web of Science ®Google Scholar
• Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–1229.
   PubMed Web of Science ®Google Scholar
• Rodriguez Iii FH, Moodie DS, Parekh DR, et al. Outcomes of heart failure–related hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8(6):513–519.
   PubMed Web of Science ®Google Scholar
• Moussa NB, Karsenty C, Pontnau F, et al. Characteristics and outcomes of heart failure-related hospitalization in adults with congenital heart disease. Arch Cardiovasc Dis. 2017 May 01;110(5):283–291.
   PubMed Web of Science ®Google Scholar
• Burchill LJ, Gao L, Kovacs AH, et al. Hospitalization trends and health resource use for adult congenital heart disease-related heart failure. J Am Heart Assoc. 2018 Aug 7;7(15):e008775. PubMed PMID: 30371225.
   PubMed Web of Science ®Google Scholar
• Oechslin EN, Harrison DA, Connelly MS, et al. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000 Sep 15;86(10):1111–1116.
   PubMed Web of Science ®Google Scholar
• Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015 Dec 1;132(22):2118–2125. PubMed PMID: 26369353.
   PubMed Web of Science ®Google Scholar
• Zomer AC, Vaartjes I, Uiterwaal CSPM, et al. Circumstances of death in adult congenital heart disease. Int J Cardiol. 2012 Jan 26;154(2):168–172.
   PubMed Web of Science ®Google Scholar
• Yu C, Moore BM, Kotchetkova I, et al. Causes of death in a contemporary adult congenital heart disease cohort. Heart. 2018;104(20):1678–1682.
   PubMed Web of Science ®Google Scholar
• Engelings CC, Helm PC, Abdul-Khaliq H, et al. Cause of death in adults with congenital heart disease — an analysis of the German national register for congenital heart defects. Int J Cardiol. 2016;211:31–36.
   PubMed Web of Science ®Google Scholar
• Naidu P, Grigg L, Zentner D. Mortality in adults with congenital heart disease. Int J Cardiol. 2017 Oct 15;245: 125–130.
   PubMed Web of Science ®Google Scholar
• Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005 Aug 9;112(6):828–835. PubMed PMID: 16061735.
   PubMed Web of Science ®Google Scholar
• Fredriksen PM, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001 Feb 1;87(3):310–314.
   PubMed Web of Science ®Google Scholar
• Bolger AP, Coats AJS, Gatzoulis MA. Congenital heart disease: the original heart failure syndrome. Eur Heart J. 2003;24(10):970–976.
   PubMed Web of Science ®Google Scholar
• Budts W, Ravekes WJ, Danford DA, et al. Diastolic heart failure in patients with the fontan circulation: a review. JAMA Cardiol. 2020;5(5):590.
   PubMed Web of Science ®Google Scholar
• Negishi J, Ohuchi H, Miyazaki A, et al. Clinical characteristics of adult patients with congenital heart disease hospitalized for acute heart failure. Circ J. 2018;82(3):840–846.
   PubMed Web of Science ®Google Scholar
• Tretter JT, Redington AN. The forgotten ventricle? The left ventricle in right-sided congenital heart disease. Circ Cardiovasc Imaging. 2018 Mar;11(3):e007410. PubMed PMID: 29855426.
   PubMed Web of Science ®Google Scholar
• Burstein DS, Menachem JN, Opotowsky AR. Exercise testing for assessment of heart failure in adults with congenital heart disease. Heart Fail Rev. 2019 Nov 4. DOI:10.1007/s10741-019-09867-1
   Web of Science ®Google Scholar
• Di Salvo G, Miller O, Babu Narayan S, et al. Imaging the adult with congenital heart disease: a multimodality imaging approach—position paper from the EACVI. Eur Heart J Cardiovasc Imaging. 2018;19(10):1077–1098.
   PubMed Web of Science ®Google Scholar
• Ortega M, Triedman JK, Geva T, et al. Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Am J Cardiol. 2011 May 15;107(10):1535–1540.
   PubMed Web of Science ®Google Scholar
• Rathod RH, Prakash A, Kim YY, et al. Cardiac magnetic resonance parameters predict transplantation-free survival in patients with fontan circulation. Circ Cardiovasc Imaging. 2014 May;7(3):502–509. PubMed PMID: 24619103.
   PubMed Web of Science ®Google Scholar
• Koyak Z, Harris L, de Groot JR, et al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012 Oct 16;126(16):1944–1954. CIRCULATIONAHA.112.104786 [pii].
   PubMed Web of Science ®Google Scholar
• Inuzuka R, Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012 Jan 17;125(2):250–259. PubMed PMID: 22147905.
   PubMed Web of Science ®Google Scholar
• Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002 Jul 2;106(1):92–99. PubMed PMID: 12093776.
   PubMed Web of Science ®Google Scholar
• Popelová JR, Kotaška K, Tomková M, et al. Usefulness of N-terminal pro-brain natriuretic peptide to predict mortality in adults with congenital heart disease. Am J Cardiol. 2015 Nov 1;116(9):1425–1430.
   PubMed Web of Science ®Google Scholar
• Baggen VJM, Baart SJ, van den Bosch AE, et al. Prognostic value of serial N-terminal Pro-B-type natriuretic peptide measurements in Adults with congenital heart disease. PubMed PMID: 29581225. J Am Heart Assoc. 2018 Mar 26;7(7). DOI:10.1161/JAHA.117.008349
   PubMed Web of Science ®Google Scholar
• Baggen VJ, van den Bosch AE, Eindhoven JA, et al. Prognostic value of N-terminal Pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease. Circulation. 2017 Jan 17;135(3):264–279. CIRCULATIONAHA.116.023255 [pii] 10.1161/CIRCULATIONAHA.116.023255. PubMed PMID: 27832613; eng.
   PubMed Web of Science ®Google Scholar
• Budts W, Roos-Hesselink J, Rädle-Hurst T, et al. Treatment of heart failure in adult congenital heart disease: a position paper of the working group of grown-up congenital heart disease and the heart failure association of the European society of cardiology. Eur Heart J. 2016;37(18):1419–1427.
   PubMed Web of Science ®Google Scholar
• Heck PB, Muller J, Weber R, et al. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation. Eur J Heart Fail. 2013 Jun;15(6):644–649. hft063 [pii] 10.1093/eurjhf/hft063 PubMed PMID: 23610138; eng.
   PubMed Web of Science ®Google Scholar
• Wolff D, Ebels T, van Melle JP. N-terminal pro brain natriuretic hormone in Fontan patients: heart failure or circulatory failure? Eur J Heart Fail. 2013 Jun;15(6):602–603. hft081 [pii] 10.1093/eurjhf/hft081. PubMed PMID: 23699071; eng.
   PubMed Web of Science ®Google Scholar
• Eindhoven JA, van den Bosch AE, Ruys TP, et al. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013 Sep 24;62(13):1203–1212. S0735-1097(13)02828-3 [pii] 10.1016/j.jacc.2013.07.019. PubMed PMID: 23916937; eng.
   PubMed Web of Science ®Google Scholar
• Geenen LW, van Grootel RWJ, Akman K, et al. Exploring the prognostic value of novel markers in adults with a systemic right ventricle. J Am Heart Assoc. 2019 Sep 3;8(17):e013745. PubMed PMID: 31431113.
   PubMed Web of Science ®Google Scholar
• Yap S-C, Harris L, Chauhan VS, et al. Identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am J Cardiol. 2011 Sep 01;108(5):723–728.
   PubMed Web of Science ®Google Scholar
• Baggen VJM, Venema E, Živná R, et al. Development and validation of a risk prediction model in patients with adult congenital heart disease. Int J Cardiol. 2019 Feb 01;276:87–92.
   PubMed Web of Science ®Google Scholar
• Baggen VJM, van den Bosch AE, van Kimmenade RR, et al. Red cell distribution width in adults with congenital heart disease: A worldwide available and low-cost predictor of cardiovascular events. Int J Cardiol. 2018 Jun 1;260:60–65. S0167-5273(17)33792-0 [pii] 10.1016/j.ijcard.2018.02.118. PubMed PMID: 29525069; eng.
   PubMed Web of Science ®Google Scholar
• Eindhoven JA, Roos-Hesselink JW, van den Bosch AE, et al. High-sensitive troponin-T in adult congenital heart disease. Int J Cardiol. 2015 Apr 1;184:405–411. S0167-5273(15)00154-0 [pii] 10.1016/j.ijcard.2015.02.027. PubMed PMID: 25746495; eng.
   PubMed Web of Science ®Google Scholar
• Geenen LW, Baggen VJM, van den Bosch AE, et al. Prognostic value of soluble ST2 in adults with congenital heart disease. Heart. 2019 Jul;105(13):999–1006. heartjnl-2018-314168 [pii] 10.1136/heartjnl-2018-314168. PubMed PMID: 30700520; PubMed Central PMCID: PMC6582725. eng.
   PubMed Web of Science ®Google Scholar
• van Hagen IM, Boersma E, Johnson MR, et al. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: results of a registry from the european society of cardiology. Eur J Heart Fail. 2016;18(5):523–533.
   PubMed Web of Science ®Google Scholar
• Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC registry of pregnancy and cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848–3855.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC). Eur Heart J. 2018;39(34):3165–3241.
   PubMed Web of Science ®Google Scholar
• Ohuchi H, Takasugi H, Ohashi H, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation. 2003 Nov 11;108(19):2368–2376. PubMed PMID: 14597592.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Bonhoeffer P, De Groot NMS, et al., Endorsed by the Association for European Paediatric C, Authors/Task Force M. ESC guidelines for the management of grown-up congenital heart disease (new version 2010): the task force on the management of grown-up congenital heart disease of the European society of cardiology (ESC). Eur Heart J. 2010;31(23):2915–2957.
   PubMed Web of Science ®Google Scholar
• Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure randomized controlled trial. Jama. 2007;298(10):1171–1179.
   PubMed Web of Science ®Google Scholar
• Nishiyama M, Park I-S, Yoshikawa T, et al. Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease. Heart Vessels. 2009 May 01;24(3):187–192.
   PubMed Web of Science ®Google Scholar
• Norozi K, Bahlmann J, Raab B, et al. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young. 2007;17(4):372–379.
   PubMed Web of Science ®Google Scholar
• Mj Lr C, Jung Kwak M, Park KH, et al. Lee HD effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies. Minerva Cardioangiol. 2015;63(6):495–505.
   PubMed Web of Science ®Google Scholar
• Babu-Narayan SV, Uebing A, Davlouros PA, et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (ace inhibitors for potential prevention of the deleterious effects of pulmonary regurgitation in adults with repaired TEtralogy of Fallot). Int J Cardiol. 2012 Feb 09;154(3):299–305.
   PubMed Web of Science ®Google Scholar
• Krupickova S, Li W, Cheang MH, et al. Ramipril and left ventricular diastolic function in stable patients with pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol. 2018;272:64–69.
   PubMed Web of Science ®Google Scholar
• Bokma JP, Winter MM, van Dijk AP, et al. Effect of losartan on right ventricular dysfunction: results from the double-blind, randomized REDEFINE trial (right ventricular dysfunction in tetralogy of Fallot: inhibition of the renin-angiotensin-aldosterone system) in adults with repaired tetralogy of Fallot. Circulation. 2018 Apr 3;137(14):1463–1471. PubMed PMID: 29222139.
   PubMed Web of Science ®Google Scholar
• Faris R, Flather M, Purcell H, et al. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol. 2002 Feb 01;82(2):149–158.
   PubMed Web of Science ®Google Scholar
• Elkiran O, Sandikkaya A, Kocak G, et al. Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts. Pediatr Cardiol. 2013 Oct 01;34(7):1583–1589.
   PubMed Web of Science ®Google Scholar
• Lopes RD, Rordorf R, De Ferrari GM, et al. Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol. 2018 Mar 13;71(10):1063–1074. S0735-1097(18)30103-7 [pii] 10.1016/j.jacc.2017.12.060. PubMed PMID: 29519345; eng.
   PubMed Web of Science ®Google Scholar
• Ziff OJ, Lane DA, Samra M, et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015 Aug;30(351):h4451. PubMed PMID: 26321114; PubMed Central PMCID: PMC4553205. eng.
   PubMed Web of Science ®Google Scholar
• McMurray JJV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 11;371:993–1004. PubMed PMID: 25176015.
   PubMed Web of Science ®Google Scholar
• Lluri G, Lin J, Reardon L, et al. Early experience with sacubitril/valsartan in adult patients with congenital heart disease. World J Pediatr Congenit Heart Surg. 2019;10(3):292–295. PubMed PMID: 31084317.
   PubMed Web of Science ®Google Scholar
• Maurer SJ, Pujol Salvador C, Schiele S, et al. Sacubitril/valsartan for heart failure in adults with complex congenital heart disease. Int J Cardiol. 2020;300:137–140.
   PubMed Web of Science ®Google Scholar
• Appadurai V, Thoreau J, Malpas T, et al. Sacubitril/valsartan in adult congenital heart disease patients with chronic heart failure − a single centre case series and call for an international registry. Heart Lung Circ. 2020 Jan 01;29(1):137–141.
   PubMed Web of Science ®Google Scholar
• McMurray JJV, DeMets DL, Inzucchi SE, et al. A trial to evaluate the effect of the sodium–glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur J Heart Fail. 2019;21(5):665–675.
   PubMed Web of Science ®Google Scholar
• Zaragoza-Macias E, Zaidi AN, Dendukuri N, et al. Medical therapy for systemic right ventricles: a systematic review (Part 1) for the 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019 Apr 2;139(14):e801–e813. PubMed PMID: 30586770.
   PubMed Web of Science ®Google Scholar
• van Dissel AC, Winter MM, van der Bom T, et al. Long-term clinical outcomes of valsartan in patients with a systemic right ventricle: follow-up of a multicenter randomized controlled trial. Int J Cardiol. 2019;278:84–87.
   PubMed Web of Science ®Google Scholar
• Tobler D, Bouchardy J, Reto E, et al. Effect of phosphodiesterase-5 inhibition with Tadalafil on systemic right ventricular size and function – A multi-center, double-blind, randomized, placebo-controlled clinical trial – SERVE trial - rational and design. Int J Cardiol. 2017;243:354–359.
   PubMed Web of Science ®Google Scholar
• Kouatli AA, Garcia JA, Zellers TM, et al. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation. 1997 Sep 2;96(5):1507–1512. PubMed PMID: 9315539.
   PubMed Web of Science ®Google Scholar
• Hsu DT, Zak V, Mahony L, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010 Jul 27;122(4):333–340. PubMed PMID: 20625111.
   PubMed Web of Science ®Google Scholar
• Yim DLS, Jones BO, Alexander PMA, et al. Effect of anti-heart failure therapy on diastolic function in children with single-ventricle circulations. Cardiol Young. 2015;25(7):1293–1299.
   PubMed Web of Science ®Google Scholar
• Mahle WT, Wang A, Quyyumi AA, et al. Impact of spironolactone on endothelial function in patients with single ventricle heart. Congenit Heart Dis. 2009;4(1):12–16.
   PubMed Web of Science ®Google Scholar
• Ishibashi N, Park I-S, Waragai T, et al. Effect of carvedilol on heart failure in patients with a functionally univentricular heart. Circ J. 2011;75(6):1394–1399.
   PubMed Web of Science ®Google Scholar
• Wang W, Hu X, Liao W, et al. The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials. Pulm Circ. 2019;9(1):2045894018790450. PubMed PMID: 29972332.
   Web of Science ®Google Scholar
• Goldberg DJ, Zak V, Goldstein BH, et al. Results of the fuel trial. Circulation. 2020 Feb 25;141(8):641–651. PubMed PMID: 31736357; PubMed Central PMCID: PMC7042084. eng.
   PubMed Web of Science ®Google Scholar
• Corrà U, Giannuzzi P, Adamopoulos S, et al. Executive summary of the position paper of the working group on cardiac rehabilitation and exercise physiology of the european society of cardiology (ESC): core components of cardiac rehabilitation in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2005 Aug;12(4):321–325. PubMed PMID: 16079638.
   PubMedGoogle Scholar
• Koukoui F, Desmoulin F, Lairy G, et al. Benefits of cardiac rehabilitation in heart failure patients according to etiology: INCARD French study. Medicine (Baltimore). 2015;94(7):e544. PubMed PMID: 00005792-201502030-00016.
   PubMed Web of Science ®Google Scholar
• Ades PA, Keteyian SJ, Balady GJ, et al. Cardiac rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail. 2013 Dec 01;1(6):540–547.
   PubMed Web of Science ®Google Scholar
• Haykowsky MJ, Daniel KM, Bhella PS, et al. Heart Failure: exercise-based cardiac rehabilitation: who, when, and how intense? Can J Cardiol. 2016 Oct 01;32(10, Supplement 2):S382–S387.
   PubMed Web of Science ®Google Scholar
• Sarno LA, Misra A, Siddeek H, et al. Cardiac rehabilitation for adults and adolescents with congenital heart disease: extending beyond the typical patient population. J Cardiopulm Rehabil Prev. 2020;40(1):E1–E4. PubMed PMID: 01273116-202001000-00012.
   PubMed Web of Science ®Google Scholar
• Opotowsky AR, Rhodes J, Landzberg MJ, et al. A randomized trial comparing cardiac rehabilitation to standard of care for adults with congenital heart disease. World J Pediatr Congenit Heart Surg. 2018;9(2):185–193. PubMed PMID: 29544423.
   PubMed Web of Science ®Google Scholar
• Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life—single centre experience and review of published data. Eur Heart J. 2011;33(11):1386–1396.
   PubMed Web of Science ®Google Scholar
• Sandberg C, Hedström M, Wadell K, et al. Home-based interval training increases endurance capacity in adults with complex congenital heart disease. Congenit Heart Dis. 2018;13(2):254–262.
   PubMed Web of Science ®Google Scholar
• Gomes-Neto M, Saquetto MB, da Silva E Silva CM, et al. Impact of exercise training in aerobic capacity and pulmonary function in children and adolescents after congenital heart disease surgery: a systematic review with meta-analysis. Pediatr Cardiol. 2016 Feb 01;37(2):217–224.
   PubMed Web of Science ®Google Scholar
• Opić P, Utens EMWJ, Cuypers JAAE, et al. Sports participation in adults with congenital heart disease. Int J Cardiol. 2015;187:175–182.
   PubMed Web of Science ®Google Scholar
• Kovacs AH, Kaufman TM, Broberg CS. Cardiac rehabilitation for adults with congenital heart disease: physical and psychosocial considerations. Can J Cardiol. 2018 Oct 01;34(10, Supplement 2):S270–S277.
   PubMed Web of Science ®Google Scholar
• Budts W, Börjesson M, Chessa M, et al. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription†. Eur Heart J. 2013;34(47):3669–3674.
   PubMed Web of Science ®Google Scholar
• Janoušek J, Kubuš P. Cardiac resynchronization therapy in congenital heart disease. Herzschrittmachertherapie Elektrophysiologie. 2016 June 01;27(2):104–109.
   PubMedGoogle Scholar
• Belkin MN, Upadhyay GA. Does cardiac resynchronization therapy benefit patients with non-left bundle branch block prolonged QRS patterns? Curr Cardiol Rep. 2017 Oct 24;19(12):125.
   PubMed Web of Science ®Google Scholar
• Cohen MI. Heart failure summit review: cardiac re-synchronisation therapy in the failing heart. Cardiol Young. 2015;25(S2):124–130.
   PubMedGoogle Scholar
• Flügge A-K, Wasmer K, Orwat S, et al. Cardiac resynchronization therapy in congenital heart disease: results from the German national register for congenital heart defects. Int J Cardiol. 2018;273:108–111.
   PubMed Web of Science ®Google Scholar
• Chubb H, O’Neill M, Rosenthal E. Pacing and defibrillators in complex congenital heart disease. Arrhythm Electrophysiol Rev. 2016 5;May(1):57–64. PubMed PMID: 27403295.
   Google Scholar
• Demetriades P, Bell A, Gubran C, et al. Suitability of cardiac resynchronisation therapy in patients with Fontan circulation and congenitally corrected transposition of the great arteries. Int J Cardiol. 2017;249:166–168.
   PubMed Web of Science ®Google Scholar
• Sharma PS, Vijayaraman P. Evolving role of permanent his bundle pacing in conquering dyssynchrony. Card Electrophysiol Clin. 2019 Mar 01;11(1):165–173.
   PubMedGoogle Scholar
• Jay PY, Harris BS, Buerger A, et al. Function follows form: cardiac conduction system defects in Nkx2-5 mutation. Anat Rec Part A: Discoveries Mol Cell Evol Biol. 2004;280A(2):966–972.
   Google Scholar
• Khairy P. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease. Heart. 2016;102(21):1703–1709.
   PubMed Web of Science ®Google Scholar
• Ávila P, Chaix M-A, Mondésert B, et al. Sudden cardiac death in adult congenital heart disease. Card Electrophysiol Clin. 2017 June 01;9(2):225–234.
   PubMedGoogle Scholar
• Khairy P, Dore A, Poirier N, et al. Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev Cardiovasc Ther. 2009 Jul 01;7(7):755–762.
   PubMedGoogle Scholar
• Probst J, Diller G-P, Reinecke H, et al. Prevention of sudden cardiac death in patients with Tetralogy of Fallot: risk assessment and long term outcome. Int J Cardiol. 2018;269:91–96.
   PubMed Web of Science ®Google Scholar
• Vehmeijer JT, Koyak Z, Zwinderman AH, et al. PREVENTION-ACHD: pRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in adults with congenital heart disease; rationale and design. Neth Heart J. 2019 Oct 01;27(10):474–479.
   PubMed Web of Science ®Google Scholar
• Yap S-C, Roos-Hesselink JW, Hoendermis ES, et al. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J. 2006;28(15):1854–1861.
   PubMed Web of Science ®Google Scholar
• Koyak Z, de Groot JR, Van Gelder IC, et al. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol. 2012 Feb;5(1):101–110. PubMed PMID: 22095638.
   PubMed Web of Science ®Google Scholar
• Garside H, Leyva F, Hudsmith L, et al. Eligibility for subcutaneous implantable cardioverter defibrillators in the adult congenital heart disease population. Pacing Clin Electrophysiol. 2019;42(1):65–70.
   PubMed Web of Science ®Google Scholar
• Lévesque V, Laplante L, Shohoudi A, et al. Implantable cardioverter-defibrillators and patient-reported outcomes in adults with congenital heart disease: an international study. Heart Rhythm. 2020 May 01;17(5, Part A):768–776.
   PubMed Web of Science ®Google Scholar
• Opić P, Utens EMWJ, Moons P, et al. Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot. Clin Res Cardiol. 2012 Sep 01;101(7):509–519.
   PubMed Web of Science ®Google Scholar
• Shah DK, Deo SV, Althouse AD, et al. Perioperative mortality is the achilles heel for cardiac transplantation in adults with congenital heart disease: evidence from analysis of the UNOS registry. J Card Surg. 2016;31(12):755–764.
   PubMed Web of Science ®Google Scholar
• Davies RR, Russo MJ, Yang J, et al. Listing and transplanting adults with congenital heart disease. Circulation. 2011 Feb 22;123(7):759–767. PubMed PMID: 21300954.
   PubMed Web of Science ®Google Scholar
• Burchill LJ, Edwards LB, Dipchand AI, et al. Impact of adult congenital heart disease on survival and mortality after heart transplantation. J Heart Lung Transplant. 2014 Nov 01;33(11):1157–1163.
   PubMed Web of Science ®Google Scholar
• Hernandez GA, Lemor A, Clark D, et al. Heart transplantation and in-hospital outcomes in adult congenital heart disease patients with Fontan: A decade nationwide analysis from 2004 to 2014. J Card Surg. 2020;35(3):603–608.
   PubMed Web of Science ®Google Scholar
• Cedars A, Vanderpluym C, Koehl D, et al. An interagency registry for mechanically assisted circulatory support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant. 2018 May 01;37(5):619–630.
   PubMed Web of Science ®Google Scholar
• Zandstra TE, Palmen M, Hazekamp MG, et al. Ventricular assist device implantation in patients with a failing systemic right ventricle: a call to expand current practice. Neth Heart J. 2019 Dec 01;27(12):590–593.
   PubMed Web of Science ®Google Scholar
• Steiner JM, Krieger EV, Stout KK, et al. Durable mechanical circulatory support in teenagers and adults with congenital heart disease: A systematic review. Int J Cardiol. 2017;245:135–140.
   PubMed Web of Science ®Google Scholar
• Deng LX, Gleason LP, Khan AM, et al. Advance care planning in adults with congenital heart disease: a patient priority. Int J Cardiol. 2017;231:105–109.
   PubMed Web of Science ®Google Scholar
• Steiner JM, Oechslin EN, Veldtman G, et al. Advance care planning and palliative care in ACHD: the healthcare providers’ perspective. Cardiol Young. 2020;30(3):402–408.
   PubMed Web of Science ®Google Scholar
• Denvir MA, Murray SA, Boyd KJ. Future care planning: a first step to palliative care for all patients with advanced heart disease. Heart. 2015;101(13):1002–1007.
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Goossens E, Gallego P, et al. Recommendations for advance care planning in adults with congenital heart disease – a position paper from the ESC working group of adult congenital heart disease, the association of cardiovascular nursing and allied professions (ACNAP), the European association for palliative care (EAPC), and the international society for adult congenital heart disease (ISACHD) re-submitted for publication in . Eur Heart J.
   Google Scholar